Long-Term Assets: The sum of all assets classified as non-current.
Passage Bio, Inc. (PASG) had Long-Term Assets of $1.72M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-7.56M |
|
-- |
|
-- |
|
$8.25M |
|
$-8.25M |
|
$0.69M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-7.56M |
|
$-8.25M |
|
$-8.12M |
|
3.21M |
|
3.21M |
|
$-2.36 |
|
$-2.36 |
|
| Balance Sheet Financials | |
$34.74M |
|
$0.83M |
|
|
Long-Term Assets |
$1.72M |
$36.46M |
|
$20.10M |
|
-- |
|
$4.61M |
|
$24.71M |
|
$11.75M |
|
$11.75M |
|
$11.75M |
|
3.21M |
|
| Cash Flow Statement Financials | |
$-12.99M |
|
$0.02M |
|
-- |
|
$46.30M |
|
$33.34M |
|
$-12.97M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-64.32% |
|
-64.32% |
|
-20.73% |
|
-64.32% |
|
$3.66 |
|
$-4.04 |
|
$-4.05 |
|